Aurora Cannabis Inc.已签署协议,以1.15亿美元的全额股票交易收购Anandia Laboratories Inc..

Anandia为根据加拿大医疗大麻规定获得许可的客户提供研究和开发服务以及分析测试。

奥罗拉首席执行官特里布斯说,这笔交易扩大了他的公司的能力,并将有助于加快产品开发。

这些公司表示,Anandia的大麻测试服务将保持独立于Aurora的运营状态。

预计今年晚些时候预计加拿大的娱乐大麻合法化,Aurora一直在加紧布局。

上个月,该公司宣布向竞争对手持牌大麻生产商MedReleaf提供32亿美元的全部股票,这是加拿大大麻行业中规模最大的一笔交易。

Aurora Cannabis Inc. has signed an agreement to buy Anandia Laboratories Inc. in an all-stock deal valued at $115 million.

Anandia provides research and development services as well as analytical testing for clients licensed under Canada’s medical cannabis rules.

Aurora CEO Terry Booth says the deal expands his company’s capabilities and will help accelerate product development.

The companies say that Anandia’s cannabis testing services will remain operationally independent of Aurora.

Aurora has been gearing up in anticipation of the legalization of recreational marijuana in Canada expected later this year.

Aurora buys MedReleaf to cement status as world’s biggest cannabis company
Last month, the company announced a $3.2-billion all-stock offer for rival licensed marijuana producer MedReleaf,the largest-ever deal in Canada’s cannabis industry.